MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2023 International Congress

    Atypical parkinsonism and psychiatric disorder in hereditary diffuse leukoencephalopathy with spheroids: a novel variant in the CSF1R gene

    M. Gea, B. Flores-Pina, D. Vilas-Rolan, A. Castillo-Gandia, C. Carrato-Moñino, K. Beyer, M. Paré-Curell, A. Massuet, L. Ispierto-González (Badalona, Spain)

    Objective: We describe the clinical, radiological and neuropathological phenotype of a patient carrying a novel variant in the CSF1R gene. Background: Hereditary diffuse leukoencephalopathy with…
  • 2023 International Congress

    Exploring brain mechanisms of identity attribution in presence hallucinations of Parkinsonian origin

    J. Potheegadoo, N. Vehar, F. Bernasconi, C. Stucker, S. Stampacchia, O. Blanke (Geneva, Switzerland)

    Objective: Study cognitive, behavioral correlates of identity of presence hallucinations in Parkinson’s disease. Background: Presence hallucination (PH), the sensation that someone is nearby when no…
  • 2023 International Congress

    Long-term dementia prevalence in Parkinson disease: Glass half-full?

    J. Gallagher, J. Fedler, C. Gochanour, R. Dobkin, D. Aarsland, R. Alcalay, M. Barrett, C. Caspell-Garcia, R. Cho, L. Chahine, A. Chen-Plotkin, C. Coffey, N. Dahodwala, J. Eberling, A. Espay, J. Leverenz, I. Litvan, E. Mamikonyan, J. Morley, I. Richard, L. Rosenthal, A. Siderowf, T. Simuni, M. York, A. Willis, S. Xie, D. Weintraub (Philadelphia, USA)

    Objective: To determine long-term, cumulative dementia prevalence rates in Parkinson disease (PD) using data from two large, ongoing, prospective observational studies. Background: Dementia is reported to occur in…
  • 2023 International Congress

    Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson’s disease

    S. Jo, JH. Oh, S. Lee, J. Lee, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the diagnostic and prognostic role of blood mitochondrial DNA copy number (mtDNA-CN) measured by whole genome sequencing (WGS) in relation…
  • 2023 International Congress

    Oculomotor parameters measured during free viewing of video differentiate Parkinson’s disease from progressive supranuclear palsy

    H. Riek, B. White, D. Brien, B. Coe, C. Fearon, S. Arnott, D. Beaton, M. Binns, S. Black, E. Finger, A. Frank, D. Grimes, A. Lang, W. Lou, C. Marras, M. Masellis, P. Mclaughlin, J. Orange, A. Peltsch, A. Roberts, T. Steeves, K. Sunderland, B. Tan, D. Tang-Wai, C. Tartaglia, D. Munoz (Kingston, Canada)

    Objective: Characterize oculomotor phenotypes comprised of saccade, pupil, and blink behaviour for progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) with differing degrees of cognitive…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study

    I. Straka, V. Bolekova, K. Cho, M. Jezberova, P. Brandoburova, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)

    Objective: The pilot study aimed to identify neuroanatomical predictors of cognitive performance in patients with iNPH. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a specific…
  • 2023 International Congress

    Unusual Neuronal Intranuclear Inclusion Disease (NIID) with initial presentation mimicking recurrent Transient Global Amnesia (TGA)

    S. Kim, WT. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report an unusual Neuronal intranuclear inclusion disease (NIID) case of a woman who initially presented recurrent Transient Global Amnesia (TGA)…
  • 2023 International Congress

    Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease-related neuropsychiatric symptoms: a Phase 3b study

    G. Alva, W. Cubala, A. Berrio, V. Abler, S. Pathak (Costa Mesa, USA)

    Objective: To evaluate the safety profile of pimavanserin in patients with neuropsychiatric symptoms related to neurodegenerative disease (NDD). Background: Patients with NDD including Parkinson’s disease…
  • 2023 International Congress

    Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

    S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)

    Objective: In the current study, we evaluated a newly developed compound with a 1,3,5-trisubstituted pyrazoline scaffold with an improved PDE5 inhibitory potency as a potential…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley